CareCloud, Inc. (NASDAQ:CCLD - Get Free Report) Director John N. Daly sold 5,000 shares of CareCloud stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $3.87, for a total transaction of $19,350.00. Following the completion of the transaction, the director now directly owns 61,750 shares in the company, valued at $238,972.50. The trade was a 7.49 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
CareCloud Trading Up 4.1 %
NASDAQ CCLD traded up $0.15 during trading hours on Thursday, reaching $3.81. The company's stock had a trading volume of 117,968 shares, compared to its average volume of 526,014. The business has a 50-day simple moving average of $3.17 and a 200 day simple moving average of $2.64. CareCloud, Inc. has a 52 week low of $1.01 and a 52 week high of $4.84. The stock has a market cap of $61.94 million, a PE ratio of -1.19 and a beta of 1.44.
Hedge Funds Weigh In On CareCloud
A number of institutional investors and hedge funds have recently added to or reduced their stakes in CCLD. XTX Topco Ltd acquired a new position in shares of CareCloud in the 3rd quarter worth approximately $42,000. Heron Bay Capital Management grew its position in CareCloud by 126.8% in the second quarter. Heron Bay Capital Management now owns 34,576 shares of the company's stock worth $66,000 after buying an additional 19,329 shares during the last quarter. Finally, Renaissance Technologies LLC increased its holdings in shares of CareCloud by 25.1% in the second quarter. Renaissance Technologies LLC now owns 107,200 shares of the company's stock valued at $206,000 after buying an additional 21,500 shares in the last quarter. 10.16% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
CCLD has been the subject of a number of research analyst reports. Benchmark reiterated a "buy" rating and issued a $4.50 price target on shares of CareCloud in a report on Friday, November 15th. Roth Capital lowered CareCloud from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, November 13th. Finally, Roth Mkm cut shares of CareCloud from a "buy" rating to a "neutral" rating and lowered their target price for the stock from $5.00 to $3.50 in a research note on Wednesday, November 13th.
Check Out Our Latest Analysis on CareCloud
About CareCloud
(
Get Free Report)
CareCloud, Inc, a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services.
Recommended Stories
Before you consider CareCloud, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CareCloud wasn't on the list.
While CareCloud currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
